{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:17:39Z","timestamp":1791289059996,"version":"4.3.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.radonc.2004.07.002","type":"journal-article","created":{"date-parts":[[2004,8,5]],"date-time":"2004-08-05T07:00:10Z","timestamp":1091689210000},"page":"305-310","source":"Crossref","is-referenced-by-count":21,"title":["Inhibitory targeting of checkpoint kinase signaling overrides radiation-induced cell cycle gene regulation: a therapeutic strategy in tumor cell radiosensitization?"],"prefix":"10.1016","volume":"72","author":[{"given":"Anne Hansen","family":"Ree","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5se","family":"Bratland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragnhild V.","family":"Nome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trond","family":"Stokke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Fodstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2004.07.002_bib1","first-page":"1391","article-title":"Apoptosis, p53, and tumor cell sensitivity to anticancer agents","volume":"59","author":"Brown","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2004.07.002_bib2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/jnci\/95.9.646","article-title":"Development of investigational radiation modifiers","volume":"95","author":"Colevas","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2004.07.002_bib3","doi-asserted-by":"crossref","first-page":"37166","DOI":"10.1074\/jbc.M103414200","article-title":"The G2 DNA damage checkpoint delays expression of genes encoding mitotic regulators","volume":"276","author":"Crawford","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.radonc.2004.07.002_bib4","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1038\/sj.onc.1206677","article-title":"P53 and radiation responses","volume":"22","author":"Fei","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.radonc.2004.07.002_bib5","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1038\/sj.onc.1206682","article-title":"DNA damage checkpoint control in cells exposed to ionizing radiation","volume":"22","author":"Iliakis","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.radonc.2004.07.002_bib6","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1200\/JCO.2003.10.044","article-title":"Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents","volume":"21","author":"Ma","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2004.07.002_bib7","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1074\/jbc.275.4.2777","article-title":"BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression","volume":"275","author":"MacLachlan","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.radonc.2004.07.002_bib8","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1038\/sj.onc.1206678","article-title":"Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation","volume":"22","author":"Powell","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.radonc.2004.07.002_bib9","doi-asserted-by":"crossref","first-page":"8952","DOI":"10.1038\/sj.onc.1207000","article-title":"Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1","volume":"22","author":"Ree","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.radonc.2004.07.002_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1054\/drup.2001.0213","article-title":"If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells","volume":"4","author":"Roninson","year":"2001","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.radonc.2004.07.002_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0898-6568(00)00080-2","article-title":"The human polo-like linase, PLK, regulates cdc2\/cyclin B through phosphorylation and activation of the cdc25C phosphatase","volume":"12","author":"Roshak","year":"2000","journal-title":"Cell Signal"},{"key":"10.1016\/j.radonc.2004.07.002_bib12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1097-2765(00)80238-5","article-title":"Genetic analysis of BRCA1 function in a defined tumor cell line","volume":"4","author":"Scully","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.radonc.2004.07.002_bib13","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1038\/sj.onc.1206954","article-title":"Small-molecule cyclin-dependent kinase modulators","volume":"22","author":"Senderowicz","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.radonc.2004.07.002_bib14","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/35023629","article-title":"Polo-like kinase-1 is a target of the DNA damage checkpoint","volume":"2","author":"Smits","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.radonc.2004.07.002_bib15","first-page":"3237","article-title":"Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier","volume":"58","author":"Tomlinson","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2004.07.002_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrc1296","article-title":"Targeting the checkpoint kinases: chemosensitization versus chemoprotection","volume":"4","author":"Zhou","year":"2004","journal-title":"Nat Rev Cancer"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814004002944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814004002944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T04:28:06Z","timestamp":1549340886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814004002944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0167814004002944"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2004.07.002","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}